Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX: $APHA.TO) (NYSE: $APHA) (CSE: $KBEV.C) (TSXV: $FIRE.V) (TSXV: $BVO.V)
Delta, Kelowna, BC - January 9, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX: $APHA.TO) (NYSE: $APHA) (CSE: $KBEV.C) ( TSXV: $FIRE.V) (TSXV: $BVO.V)
Hear Investor ideas cannabis potcast on iTunes
Today's podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we will be looking at announcements from Aphria Inc. (TSX:APHA) (NYSE:APHA), Koios Beverage Corp. (CSE:KBEV) (OTC:KBEVF), The Supreme Cannabis Company, Inc. (TSXV: FIRE) (OTCQX: SPRWF) and Zenabis Global Inc. (TSXV:BVO)
Aphria Inc. today announced that it had completed its previously announced acquisition of CC Pharma GmbH, a leading distributor of pharmaceutical products, including medical cannabis, to more than 13,000 pharmacies in Germany, as well as throughout Europe. The Company continues to strengthen its end-to-end cannabis operations and infrastructure in Germany.
"As one of the most promising medical cannabis markets in the world, Germany is a top strategic priority for Aphria. With today's acquisition of CC Pharma, Aphria is creating a German and ultimately pan-European platform that brings together demand, supply and distribution." said Vic Neufeld, CEO of Aphria. "We're excited to welcome the CC Pharma team and the pharmacists they serve to the Aphria family."
CC Pharma is a leading importer and distributor of EU-pharmaceuticals for the German market. Founded in 1999, today it has over 230 employees and offices in Germany, Denmark, Poland and the Czech Republic. CC Pharma holds 318 active German national pharmaceutical licenses and 692 active EU pharmaceutical licenses, and also operates a production, repackaging and labeling facility at its headquarters in Densborn, Germany. During 2018, CC Pharma generated revenue of approximately €262 million, with EBITDA of approximately €10.5 million.
Aphria Inc. also announced that it has completed its first shipment of medical cannabis to Shoppers Drug Mart.
"As the first licensed producer to partner with Shoppers Drug Mart, we are pleased to have reached this milestone," said Vic Neufeld, Chief Executive Officer of Aphria. "This marks another important step for medical cannabis in Canada providing improved access for patients in need across the country. We are thrilled that they now have the ability to access Aphria's renowned medical cannabis products through Shoppers Drug Mart's newly launched ecommerce site - cannabis.shoppersdrugmart.ca."
"The potential cannabis has for medical purposes is still largely untapped and Aphria remains committed to investing in developing new and innovative products that address unmet patient needs. For example, we will start to produce a thin, quick-dissolve strip that may provide an effective and accurate dose delivery," added Neufeld.
Koios Beverage Corp. announced that its beverage products are now available for purchase at Tony's Meats and Market - one of Denver's top family-owned butcher and upscale grocery chains.
The Company's line of nootropic functional beverages is a good fit with that upscale market, says Chris Miller, chief executive officer of Koios.
"The owners of Tony's are a lot like us, in that they have a passion for healthy products that create real benefits for their customers," said Miller. "We share similar values not only from a business perspective but as a people. Their customers are health conscious, looking for the highest quality and have an interest in products that are organic and environmentally sustainable."
The announcement is part of the Company's strategy to grow its distribution network and get its products in front of new customers in the ever-growing market of nootropics and functional beverages.
The Supreme Cannabis Company, Inc. announced today that it has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX.
"Graduating to the TSX will broaden our investment appeal and leave us well positioned to execute on our strategic imperatives for 2019, which is why we're pleased to add this milestone to our list of accomplishments for the year," said Navdeep Dhaliwal, CEO of Supreme Cannabis.
"Our Company had a banner year that was headlined by our wholly-owned subsidiary, 7ACRES, generating the sixth highest revenue among Canadian licensed cannabis producers this past quarter. On a revenue basis, the first year of cannabis sales for 7ACRES was one of the best among any Canadian licensed cannabis producer, validating our belief that long-lasting value flows from foundational investments in high-end cannabis cultivation. Looking forward, we are eager to build on these accomplishments and make significant advancements by cementing 7ACRES as a leading premium flower brand, establishing export channels for Medigrow, launching jointly-developed products with Khalifa Kush Enterprises and more in 2019."
Final approval of the listing is subject to the Company meeting certain customary conditions required by the TSX. Supreme Cannabis will issue a statement once the TSX confirms the date on which trading on the TSX will commence. Upon completion of the final listing requirements, Supreme Cannabis' common shares will be delisted from the TSXV and will commence trading on the TSX under the symbol "FIRE".
Zenabis Global Inc. announced that they have entered into an arrangement with Manitoba Liquor and Lotteries Corporation ("MBLL") to list non-medical adult-use cannabis throughout the province to licensed retailers approved for non-medical adult-use cannabis sales. Zenabis will sell under the premium Namaste brand. Namaste's products include all forms of dried cannabis.
Zenabis expects to start supplying Manitoba retailers with cannabis in February 2019. It is anticipated that product demand will shift into new categories such as edibles (including beverages) and concentrates (including cartridges) when, and as permitted by applicable laws.
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment